Apex, NC, United States of America

Donald Alan Patrick

This inventor holds 2 USPTO granted patents. Top assignees: The University of North Carolina at Chapel Hill, University of Washington, Other. Active years: 2011-2019.


% Patents Active = 50.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2011-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Donald Alan Patrick

Introduction

Donald Alan Patrick is an accomplished inventor based in Apex, North Carolina. He holds two patents that contribute significantly to the field of medical research, particularly in the treatment of neurological disorders.

Latest Patents

His latest patents include "Compounds for treatment of trypanosomes and neurological pathogens and uses thereof." This invention relates to novel compounds that effectively cross the blood-brain barrier and inhibit neurological pathogens such as trypanosomes. The compounds are designed for treating disorders associated with these pathogens. Another notable patent is "Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles." This patent describes novel dicationic 3,5-diphenylisoxazole compounds, providing synthetic routes to these compounds. Several of them displayed in vitro activity comparable to that of furamidine, while also being less toxic to VERO cells.

Career Highlights

Donald has worked at prestigious institutions, including the University of North Carolina at Chapel Hill and the University of Washington. His work has focused on developing innovative solutions to complex medical challenges.

Collaborations

He has collaborated with notable colleagues such as Richard Ray Tidwell and Frederick Simmons Buckner, contributing to advancements in his field.

Conclusion

Donald Alan Patrick's contributions to medical research through his patents highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in the treatment of neurological disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…